Immunogenicity: Clinical Trials

3 trials for Immunogenicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B
Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered) - Immunogenicity, Safety
Phase 3CompletedPT Bio Farma2202020-10-132022-01-18
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
Vi-DT Typhoid Conjugate Vaccine, PQed Typhoid Conjugate Vaccine, Vi Polysaccharide Vaccine - Safety Issues, Immunogenicity
Phase 3CompletedPT Bio Farma30712020-03-022022-01-04
Protectivity and Safety Following Recombinant Hepatitis B Vaccine
Recombinant Hepatitis B vaccine, Recombinant Hepatitis B (Bio Farma) - Immunogenicity
Phase 2 / Phase 3CompletedPT Bio Farma5362019-09-112022-09-19

Interventions

Hepatitis B Vaccines (1)  ·  Vi polysaccharide vaccine, typhoid (1)

Sponsors

PT Bio Farma (3)

Countries

Indonesia (3)

Top investigators

Bernie E Medise, MD (1)  ·  Eddy Fadliyana (1)  ·  Yetty M Nency, MD (1)